wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33633424-064EE1A8-4DAC-4FE2-AF15-13FD3F826A13
Q33633424-064EE1A8-4DAC-4FE2-AF15-13FD3F826A13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-064EE1A8-4DAC-4FE2-AF15-13FD3F826A13
Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patients.
P2860
Q33633424-064EE1A8-4DAC-4FE2-AF15-13FD3F826A13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-064EE1A8-4DAC-4FE2-AF15-13FD3F826A13
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4348b9bfecc1351499192d9273e048bd3f660e13
P2860
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial